| Name | N-Cbz-L-histidine |
|---|---|
| Synonyms |
N-ALPHA-BENZYLOXYCBONYL-L-HISTIDINE
Z-L-HISTIDINE Nα-Carbobenzoxy-L-histidine N(alpha)-Benzyloxycbonyl-L-histidine~Z-His-OH Nα-Cbobenzoxy-L-histidine > Nα-Cbobenzyloxy-L-histidine Cbz-L-Histidine N-Cbz-L-histidine //BP (S)-2-BENZYLOXYCBONYLAMINO-3-(3H-IMIDAZOL-4-YL)-PROPIONIC ACID N-Alpha-Cbz-Histidine 2-(benzyloxycbonylamino)-3-(1H-imidazol-5-yl)propionic acid EINECS 239-084-0 Z-His-OH N-CBZ-L-HISTIDINE N(ɑ)-Benzyloxycbonyl-L-histidine (S)-2-(((Benzyloxy)carbonyl)amino)-3-(1H-iMidazol-4-yl)propanoic acid MFCD00065960 n(à)-benzyloxycbonyl-l-histidine Carbobenzoxy-dl-histidine N(alpha)-Benzyloxycbonyl-L-histidine Nα-Cbobenzoxy-L-histidine N(a)-Benzyloxycbonyl-L-histidine N-CBZ-L-HISTIDINE-OH (2S)-2-{[(benzyloxy)carbonyl]amino}-3-(1H-imidazol-5-yl)propanoic acid Na-Carbobenzyloxy-L-histidine CBZ-L-Histidine-OH N-CBOBENZOXY-L-HISTIDINE CBZ-L-HIS-OH CBZ-HIS-OH Z-L-His 5-(10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-hexanone Nα-Cbz-L-histidine N-[(Benzyloxy)carbonyl]-L-histidine 3-(1H-imidazol-5-yl)-2-(phenylmethoxycbonylamino)propanoic acid Z-L-His-OH Z-HIS-OH Nα-(Benzyloxycbonyl)histidine Nα -Cbz-L-histidine, [Z-His-OH] N-benzyloxycbonyl-L-histidine Nα-Z-L-histidine Z-HISTIDINE N(^a)-Benzyloxycbonyl-L-histidine Z-L-HISTIDINE extrapure (2S)-2-{[(benzyloxy)carbonyl]amino}-3-(1H-imidazol-4-yl)propanoic acid N(α)-Cbobenzyloxy-L-histidine Nα-Cbobenzyloxy-L-histidine, Nα-Z-L-Histidine N-α-Z-L-histidine (S)-2-(((Benzyloxy)carbonyl)amino)-3-(1H-imidazol-4-yl)propanoic acid Nalpha-Cbz-L-histidine Z-His-OH (2S)-3-(1H-imidazol-5-yl)-2-(phenylmethoxycarbonylamino)propanoic acid N2-CBOBENZYLOXY-L-HISTIDINE N(ALPHA)-CBZ-L-HISTIDINE Na-Cbz-L-histidine N-ALPHA-CBOBENZYLOXY-L-HISTIDINE n(à)-cbz-l-histidine Z-HIS Nα-Cbobenzoxy-L-histidine,Nα-Cbz-L-histidine N-ALPHA-Z-L-HISTIDINE NALPHA-CBOBENZOXY-L-HISTIDINE |
| Description | Z-His-OH is a histidine derivative[1]. |
|---|---|
| Related Catalog | |
| In Vitro | Amino acids and amino acid derivatives have been commercially used as ergogenic supplements. They influence the secretion of anabolic hormones, supply of fuel during exercise, mental performance during stress related tasks and prevent exercise induced muscle damage. They are recognized to be beneficial as ergogenic dietary substances[1]. |
| References |
| Density | 1.4±0.1 g/cm3 |
|---|---|
| Boiling Point | 616.7±55.0 °C at 760 mmHg |
| Melting Point | 168 °C (dec.)(lit.) |
| Molecular Formula | C14H15N3O4 |
| Molecular Weight | 289.287 |
| Flash Point | 326.8±31.5 °C |
| Exact Mass | 289.106262 |
| PSA | 104.31000 |
| LogP | 1.20 |
| Vapour Pressure | 0.0±1.9 mmHg at 25°C |
| Index of Refraction | 1.614 |
| Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| Hazard Codes | Xn |
| Risk Phrases | R20/21/22 |
| Safety Phrases | S22-S24/25 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | 3 |
| HS Code | 2933290090 |
| Precursor 9 | |
|---|---|
| DownStream 6 | |
| HS Code | 2933290090 |
|---|---|
| Summary | 2933290090. other compounds containing an unfused imidazole ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |